Serum protein-bound hexosamine in tumours of the genital tract

Serum protein-bound hexosamine was estimated in one hundred and four women. In patients with fibroid uterus there was an increase in its level. In the malignancy group of patients there was a highly statistically significant increase in its mean than that of controls. Its level could be of value in early detection of cancer body

Serum protein-bound sialic acid in tumours of the genital tract

Serum protein-bound sialic acid was estimated in one hundred and four women. There is no statistical difference in patients with fibroid uterus. There is an increase in malignant tumours and this is more in inoperable cases. This might be of value in determining the extent of the malignat tumour

glycoprotein, seromucoid in tumours of the genital tract

A specific glycoprotein, the seromucoid was studied in one hundred and four women. In patients with fibroid uterus it showed a highly significant statistical increase in its mean than that of the control group. In the malignant group of patients its level was more marked than that of fibroid cases. It was shown to be of value in the follow up of malignant cases after treatment

Serum protein-bound fucose in tumours of the genital tract

Serum protein-bound fucose was estimated in one hundred and four women. In patients with fibroid uterus there was a highly statistically significant increase in its level. This increase was more in small-sized than in big-sized fibroid. The malignant group showed a highly statistically significant increase in its level

Serum protein-bound hexose in tumours of the female genital tract

Serum protein-bound hexose was estimated in one hundred and four women. In patients with fibroid uterus no change was detected. A highly statistically significant increase was shown in malignant tumours. This increase was more in late inoperable cases which suggested its use in evaluating the extent of malignancy